Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
HSIC
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Henry Schein Announces Chief Financial Officer Leadership Transition
Emmanuel Caprais, former Senior Vice President and CFO of ITT, Inc., to become Henry Schein's CFO effective November 4, 2026. Mr. Caprais will join the Company in an advisory capacity beginning October 12, 2026, to support a structured tra…
3 Low-Volatility Stocks with Open Questions A stock with low volatility can be reassuring, but it doesn't always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. L…
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Henry Schein (HSIC) or Merit Medical (MMSI). But which of these two stocks presents investors with the better value opportunity right now? L…
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to…
Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry Schein
Company Logo The global dental implants and prosthetics market is projected to grow from USD 12.79 billion in 2026 to USD 17.67 billion by 2031, at a 6.7% CAGR. Growth is driven by rising tooth loss, an aging population, demand for cosmeti…
Dental Equipment & Technology Stocks Q2 Earnings Review: Envista (NYSE:NVST) Shines As the Q2 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the dental equipment & technology indust…
Henry Schein Cares Marks 25 Years of Helping Health Happen®
Fred Lowery, Chief Executive Officer of Henry Schein, and Diane Brady, Executive Editorial Director of Fortune, participate in a fireside chat during Henry Schein Cares' 25th anniversary celebration in New York City, reflecting on the Comp…
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings?
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings? Henry Schein trades at $86.39 and has moved in lockstep with the market. Its shares have returned 18.8% over the last six months while the S&P 500 has gained 21.4%. Is there a buyin…
Henry Schein (HSIC) Extends Credit Facility, Is The Stock Still Undervalued?
Henry Schein (HSIC) is back in focus after amending and restating its revolving credit facility, increasing total commitments to $1.25 billion and extending the termination date to September 19, 2031. Against that backdrop, Henry Schein's…
Henry Schein (HSIC) Stock Looks Below Fair Value Even After A 31% Gain
Henry Schein has delivered a 30.7% share price gain over the past year, which naturally puts the spotlight on whether that move is backed by the cash the business is expected to generate. With the stock recently closing at US$86.37, the ke…
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how dental equipment…
3 Cash-Producing Stocks That Concern Us A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies are created equal, and Stoc…
Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus
Wall Street's major market averages finished mixed as Treasury yields rebounded, rekindling concerns about a deteriorating macroeconomic backdrop. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-ne…
Are Investors Undervaluing Henry Schein (HSIC) Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growt…
Henry Schein (HSIC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating chang…
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now? We'll need…
DermaSensor Raises $5 Million and Opens Round to the Public via Wefunder, Alongside Four Major New US Partnerships
MIAMI, September 09, 2026--(BUSINESS WIRE)--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, announced today the close of a $4M Series B extension, including institutional and strategic investors, alongside the l…
Henry Schein to Participate in Upcoming Investor Conference in September
MELVILLE, N.Y., September 08, 2026--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following…
Q2 Earnings Outperformers: Align Technology (NASDAQ:ALGN) And The Rest Of The Dental Equipment & Technology Stocks
Q2 Earnings Outperformers: Align Technology (NASDAQ:ALGN) And The Rest Of The Dental Equipment & Technology Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look…
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can…
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
It has been about a month since the last earnings report for Henry Schein (HSIC). Shares have added about 0.9% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leadi…
Is Henry Schein (HSIC) Stock Undervalued Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at val…
Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?
Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside re…
DermaSensor Announces Four Major New Industry Partnerships to Accelerate Growth in the US
MIAMI, September 01, 2026--(BUSINESS WIRE)--DermaSensor Inc., a leader in AI-powered skin cancer diagnostic technology, today announced a major expansion of its U.S. commercial strategy through a series of strategic partnerships to acceler…
Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis
MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the "MD Sass Concentrated Value Strategy." The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led…
From Decline to Momentum: Primo Brands’ (PRMB) Impressive Q2 Comeback
MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the "MD Sass Concentrated Value Strategy." The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led…
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors? We'll need to take a clo…
Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?
Henry Schein, Inc. HSIC is showing broader growth and a better earnings outlook, but the investment case is not free of execution risk. Second-quarter gains spanned distribution, specialty products and technology, while management raised i…
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein, Inc. HSIC raised its 2026 sales and earnings outlook after a second quarter marked by faster internal growth and better profitability. Net sales increased 6.7% to $3.46 billion, while adjusted earnings of $1.27 per share exce…
3 Unpopular Stocks with Open Questions When Wall Street turns bearish on a stock, it's worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other busine…
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align Technology ALGN is dealing with a new U.K. tax issue in 2026. A July Upper Tribunal decision overturned the prior value-added tax exemption for clear aligners, adding a fresh earnings and pricing variable. The ruling arrives as inter…
Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now
The Cooper Companies, Inc.'s COO growth is fueled by CooperVision's premium lens migration and MiSight's myopia-management leadership, supported by CooperSurgical's women's health and fertility portfolio. However, channel volatility, priva…
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call
5 Insightful Analyst Questions From Henry Schein's Q2 Earnings Call Henry Schein delivered a positive second quarter, with results exceeding Wall Street's expectations and earning a strong market response. Management attributed the outperf…
Henry Schein (HSIC) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Fred Lowery Senior Vice President and Chief Financial Officer - Ron South Vice President of Investor Relations and Strate…
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly l…
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?…